800-680-7137Call For Help With Addiction
Talk To Someone Now
- Find a Clinic Near You
- Access Help and Resources
- Get 24-Hour Guidance and Information
SponsoredMethadone Clinics in cities of Washington
MOUD Treatment in Washington: The Statewide Picture
Washington offers medication treatment for opioid use disorder across a wide split between dense urban centers and rural counties. King, Pierce, Snohomish, and Spokane counties hold most of the state’s opioid treatment programs (OTPs), while counties east of the Cascades and along the coast often rely on office-based prescribers and telehealth to fill the gaps.
Statewide, fentanyl drives almost all opioid deaths, and the response has been built around all three FDA-approved medications: methadone, buprenorphine (including Suboxone), and naltrexone.
The listings on this page route by city. The context below covers what is consistent statewide.
Your Treatment Options and Where Each Is Available
Three medications are approved to treat opioid use disorder, and each is offerd in a different setting. Methadone for OUD is dispensed only through a licensed opioid treatment program. You receive your dose at the program and may become eligible for take-home doses as treatment stabilizes.
Buprenorphine, including Suboxone and the extended-release injection Sublocade, can be prescribed in a regular doctor’s office by any clinician with a standard DEA registration, then filled at a pharmacy, or it can be provided through an OTP. Since the federal X-waiver requirement was removed in 2023, primary care physicians, nurse practitioners, and physician assistants across Washington can prescribe it, which has widened where buprenorphine is available.
Naltrexone, including the monthly Vivitrol injection, is not a controlled substance and can be prescribed by any licensed provider. Naltrexone treatment can only begin after a person has stopped using opioids for a set period to avoid precipitated withdrawal.
How methadone and Suboxone compare is the most common consideration people face. Both are effective. The right choice depends on your medical history, how stable your daily schedule is, and what your clinician recommends.
The structure of an opioid treatment program differs from office-based care, and the listings below show which clinics in Washington offer which option.
Washington’s Hub and Spoke Model and How MOUD Reaches the Whole State
Washington built one of the country’s first statewide systems for routing people into MOUD regardless of where they walk in. The Hub and Spoke Project, administered by the Washington State Health Care Authority’s Division of Behavioral Health and Recovery and originally funded through the federal State Opioid Response grant, connects hub sites with MOUD expertise to spoke partners across primary care, behavioral health, and outreach settings.
A patient who shows up at a community health center can be linked to a prescriber that day, with a nurse care manager handling the coordination. As of the program’s most recent evaluations in 2025, the model operates across 11 hub networks statewide and includes methadone, buprenorphine, and extended-release naltrexone. For people in counties without a nearby OTP, the spoke side of this network is often how buprenorphine first reaches them.
Apple Health, Telehealth, and Current Rules on Take-homes
Apple Health, Washington’s Medicaid program, covers all three medications for opioid use disorder, and the Health Care Authority’s MOUD policy for both adults and youth requires no prior authorization for methadone, buprenorphine, or naltrexone. If you have Apple Health, your managed care plan should cover treatment at any participating provider. Most private plans in Washington also cover MOUD, and OTPs typically offer self-pay or sliding-scale options when insurance is not in place.
Federal rules updated in 2024 expanded take-home methadone (up to a 28-day supply for stable patients on a graduated schedule), authorized starting treatment by telehealth, and removed the older requirement of a one-year history of opioid use before OTP admission. Take-home eligibility is decided by the program based on your stability in treatment, not on the calendar.
For buprenorphine, federal telemedicine flexibilities run through December 31, 2026, which means you can usually be evaluated and started by phone or video without a prior in-person visit. The rules are still being finalized at the federal level, so confirm what is current when you call a provider.
Where Washington Stands on Fentanyl and Overdose
As of 2025, synthetic opioids, mostly fentanyl, now account for more than 90% of opioid-involved deaths in Washington. After years of sharp increases, 2024 brought the first decline: an estimated 3,167 opioid overdose deaths statewide, down from 3,597 in 2023, about a 12% drop based on provisional CDC data.
The drop was steeper in King County, where deaths fell from 1,340 in 2023 to 1,042 in 2024. State health officials have urged caution about whether the decline is sustained, and preliminary 2025 data suggest some rebound.
Fentanyl mixed with methamphetamine is now the most common combination among opioid deaths in Washington, which makes overdose risk harder to predict from one use to the next. Medication treatment for opioid use disorder is the most effective response, and the listings on this page show where to start.
How to Start Treatment in Washington
The first step is an assessment, which can happen at a clinic or, for buprenorphine, by phone or video. An OTP will ask about your opioid use history, current health, and any other medications, and they may begin dosing the same day if you are in withdrawal.
For buprenorphine, the timing of the first dose matters. Starting too soon after using fentanyl can trigger sudden, severe withdrawal (called precipitated withdrawal), so a clinician will help you time induction.
Some Washington providers use a low-dose start, sometimes called the Bernese method, when fentanyl is in the picture. Starting methadone after fentanyl use works differently and does not carry the same precipitated withdrawal risk.
Inpatient programs are also available in Washington for people who need a higher level of care, and these programs can be combined with medication.
Pregnancy, Reentry, and Other Situations That Need a Tailored Path
If you are pregnant and have opioid use disorder, the medical standard of care is methadone or buprenorphine, not withdrawal. Both are safer for the pregnancy than continued use or untreated withdrawal, and Washington providers experienced in perinatal MOUD can coordinate prenatal care with treatment.
Methadone in pregnancy has the longest track record. Buprenorphine is also well established. Neonatal opioid withdrawal syndrome (NOWS) can occur with either medication and is managed by the hospital.
For people leaving incarceration, the Health Care Authority’s Reentry Initiative under the Medicaid Transformation Project provides up to 90 days of pre-release Apple Health services, including MOUD continuity, for eligible adults and youth. Cohorts 1 and 2 of participating facilities are live as of March 2026, and HCA is adding additional sites.
The goal is no gap between in-custody treatment and community care, which is when overdose risk after release is highest. King County’s jail program, for example, continues buprenorphine and methadone in custody and schedules a same-day MOUD appointment at release with a seven-day supply of buprenorphine.
Families helping someone restart treatment after a release date or a return to use will find that most Washington OTPs will accept transfers and prior patients without requiring a long waiting period.
Naloxone and Overdose Response Across Washington
Naloxone, the medication that reverses an opioid overdose, is widely available in Washington. The Washington State Department of Health has issued a statewide standing order under RCW 69.41.095, which lets any person or organization obtain naloxone from a pharmacy without an individual prescription, and Narcan nasal spray is also sold over the counter. Free naloxone by mail is available statewide through the University of Washington Addictions, Drug and Alcohol Institute and the stopoverdose.org program.
Washington’s 911 Good Samaritan Overdose Law (RCW 69.50.315) protects the person overdosing, as well as anyone who calls for help, from drug-possession charges. If you or someone in your home uses opioids, carry naloxone. A return to use is a common part of recovery from a chronic condition. Knowing what to do during an overdose is the difference between a survivable event and a fatal one.
Common Questions About MOUD in Washington
Does Apple Health cover methadone and Suboxone in Washington?
Yes. Apple Health covers all three FDA-approved medications for opioid use disorder, including methadone at an OTP, buprenorphine (Suboxone) at an office or OTP, and naltrexone (Vivitrol), with no prior authorization required. If you are enrolled in an Apple Health managed care plan, your plan should direct you to participating providers.
Can I start Suboxone by telehealth in Washington?
In most cases, yes. Federal telemedicine flexibilities allowing buprenorphine to be started by audio-only or audio-visual visit, without a prior in-person evaluation, run through December 31, 2026. Permanent federal rules for buprenorphine telehealth are also in place. A Washington provider can confirm which pathway fits your situation and whether any in-person follow-up is required.
Do I have to go to a clinic every day for methadone?
At the start of treatment, yes. As you stabilize, OTPs can authorize take-home doses on a graduated schedule, with up to a 28-day supply for patients judged stable under federal rules updated in 2024. Each program decides take-home eligibility based on the federal criteria and its own clinical review. Long-term methadone treatment looks different at month one than at year one.
What if my nearest OTP is far away?
This is common in rural Washington. The Hub and Spoke network often makes buprenorphine available locally through a primary care or behavioral health spoke, and telehealth lets you start and continue buprenorphine without long drives. For methadone, some patients travel to the nearest OTP during induction, then move to less frequent visits as they earn take-homes.
Is methadone an opioid? Will I still be addicted?
Methadone is a long-acting opioid medication used to treat opioid use disorder. It prevents withdrawal and cravings without producing the highs and lows of short-acting opioids like fentanyl or heroin.
Taken as prescribed, it allows people to work, parent, and live without active opioid use, and federal guidance treats long-term medication as legitimate care, not an unfinished step. Whether methadone causes physical dependence or active addiction is a useful question to bring to a clinician, and the distinction matters.
About This Page
Last reviewed June 2026.
Sources:
- SAMHSA, 42 CFR Part 8 Final Rule (2024) and MOUD overview. SAMHSA
- DEA and HHS, Fourth Temporary Extension of Telemedicine Flexibilities (Federal Register, December 2025); Expansion of Buprenorphine Treatment via Telemedicine Encounter (final rule). DEA
- Washington State Health Care Authority, Hub and Spoke Project; Reentry Initiative; Apple Health MOUD Fact Sheet (2024).
- University of Washington Addictions, Drug and Alcohol Institute, Washington State Opioid Trends (2025).
- Public Health Seattle and King County, Overdose Deaths Dashboard (2025). King County
- stopoverdose.org, Washington Good Samaritan Law (RCW 69.50.315; RCW 69.41.095).
- Health Affairs Scholar, “Effectiveness of Washington State’s hub and spoke model” (2025).
Last Updated: August 31, 2026
MethadoneCenters.com is a referrer service that provides information about addiction treatment practitioners and facilities. MethadoneCenters.com is not a medical provider or treatment facility and does not provide medical advice. The information provided is not a substitute for professional treatment advice.
Calls to any general helpline on this site may be answered or returned by a paid advertiser. There is no obligation to enter treatment.